There is a specific kind of knowledge about how policy failures work that exists in exactly one place and that the institutions making decisions about those failures consistently lack. It is not in the academic literature. It is not in the think tank reports. It is not in the regulatory filings or the congressional testimony or the policy briefs that circulate among the people who shape the formal analytical record.
It is in the lived experience of the people bearing the cost.
The patient who has been through prior authorization denial knows something about how the denial system actually operates that no policy analyst studying the system from the outside knows. The family caregiver navigating long-term care financing knows something about what the absence of a financing system actually costs — in money, in time, in health, in family relationships — that no researcher who has studied long-term care policy without living it knows. The resident dealing with a data center proposal knows something about how the permitting process actually works at the community level that no environmental regulatory expert who has never faced a specific proposal in their own neighborhood knows.
This is what the coverage map for this series calls affected-party knowledge. It is specific, contextual, tacit, and irreplaceable. It is also, in the current structure of American civic life, largely invisible to the institutions making decisions about the problems it illuminates.
Why this knowledge doesn’t reach the institutions
The absence of affected-party knowledge from formal policy deliberation is not an oversight. It is a structural outcome.
Formal policy processes — regulatory proceedings, congressional hearings, agency rule-making — are designed for institutional participants. The comment period format requires written analytical submissions. The congressional testimony format requires expert credentials or organizational standing. The agency stakeholder process requires the capacity to participate in repeated, technical proceedings over extended time periods. These processes were not designed to exclude affected parties. They were designed around the organizational capacities that institutional participants have and that most affected parties lack.
The result is that the formal analytical record in any major policy domain is built primarily from the contributions of people with institutional standing: industry association representatives, academic researchers, policy think tanks, professional advocacy organizations. Affected parties occasionally break through — a patient testifying before Congress, a family caregiver at a regulatory hearing — but these appearances are episodic, they are often framed as human interest illustration rather than analytical input, and they do not constitute a systematic mechanism for aggregating affected-party knowledge into the formal record.
The organized interests side does not face this problem because their affected parties — the pharmaceutical manufacturers, the hospital systems, the insurance companies — are institutional actors by definition. They have the organizational standing, the analytical capacity, and the sustained presence to participate fully in formal policy processes. Their knowledge reaches the institutions because they built infrastructure to deliver it there.
What the knowledge gap actually produces
When the people bearing the cost of a policy failure have no mechanism to aggregate and deliver their knowledge, the institutions making decisions about that failure are operating with systematically incomplete information.
The FDA’s approval process for pharmaceutical products relies heavily on clinical trial data submitted by manufacturers and on the academic literature that those manufacturers have significant capacity to shape. Patient experience data — what it is actually like to manage a condition with the approved treatments, what side effects actually manifest in the full patient population rather than in clinical trial cohorts, what access barriers actually prevent patients from using treatments that are theoretically available to them — is collected episodically and not systematically integrated into the regulatory decision-making that determines what gets approved, what gets priced, and what gets covered.
The result is a regulatory apparatus that is highly sophisticated about pharmaceutical chemistry and clinical efficacy and systematically underinformed about the human experience of the system it regulates. The approval decision is made with detailed quantitative data about a narrow set of outcomes and limited systematic data about the full range of patient experience that the policy is supposed to serve.
Insurance regulatory proceedings show the same pattern. State insurance commissioners reviewing rate filings and network adequacy standards hear extensively from insurance company actuaries and from healthcare provider associations. They hear rarely and unsystematically from patients who have experienced the consequences of narrow networks, from people who have navigated prior authorization denial, from families trying to find in-network mental health providers in regions where none are available. The regulatory decisions are not made by people who are hostile to patients. They are made by people who have sophisticated quantitative information about insurer financial models and limited systematic information about patient experience.
What collective wisdom requires
The philosopher James Surowiecki documented the conditions under which groups make better decisions than experts: diversity of perspective, independence of judgment, decentralization of information, and a working aggregation mechanism. Each condition matters. Together they produce what he called the wisdom of crowds — not the average of uninformed opinion, but the aggregated judgment of people reasoning from genuinely different information and experience.
Affected-party knowledge meets three of the four conditions naturally. The people bearing the cost of a policy failure have diverse perspectives — they are navigating the same system from different positions, with different constraints, with different baseline conditions. They are largely independent in their judgments — they are not coordinated by an organizational infrastructure that shapes what they think before they think it. They are decentralized in their information — each carries specific, contextual knowledge that reflects their specific position in the system.
What they lack is the aggregation mechanism. The mechanism that collects their independent, diverse, decentralized knowledge and makes it accessible to the deliberative process in a form that can shape outcomes. Without that mechanism, the collective wisdom that exists in the distributed experience of millions of people navigating a broken system remains distributed. It does not become collective. It does not become accessible. It does not reach the institutions making decisions about the system those people are navigating.
The forum on America’s Plan is designed to be that aggregation mechanism.
What the sentiment stage actually does
The first stage of America’s Plan’s four-stage pipeline is the Sentiment stage. The name understates what it is designed to collect.
Sentiment, in the common usage, means opinion. What people feel about something. The Sentiment stage is not primarily collecting opinion. It is collecting knowledge — the specific, contextual, experiential knowledge that affected parties carry and that the formal analytical record lacks.
When a patient describes what prior authorization denial actually looks like from inside the system — the specific sequence of denial letters, the specific documentation requirements that recur across denials, the specific ways the appeals process operates in practice rather than in policy — they are not expressing an opinion about healthcare policy. They are providing data that the formal analytical record does not contain. Data about how the system actually operates at the ground level, from the perspective of the person it is designed to serve.
When a family caregiver describes what the absence of long-term care financing actually costs their family — the specific financial calculations, the specific employment consequences, the specific health impacts on the caregiver as well as the care recipient — they are not expressing an opinion about long-term care policy. They are providing knowledge about what the absence of a policy produces at the human level. Knowledge that the policy analysis of why a long-term care financing system does not exist — the political economy of its absence, the interest groups who have blocked it — does not contain.
This is the knowledge the forum is designed to aggregate. Not as anecdote. As systematic input to the deliberative process that the Plan stage depends on. The policy alternatives that emerge from the Plan stage are supposed to be grounded in what affected parties actually experience — not in what institutional analysts believe affected parties experience, which is a systematically less accurate approximation.
Why organized interests cannot manufacture this
The organized interests side is fully aware of the value of affected-party knowledge. They are not unaware that patient testimony is more persuasive than actuarial analysis in certain political contexts. They invest significantly in manufacturing the appearance of affected-party support — patient advocacy organizations funded by pharmaceutical manufacturers, community groups formed by industry to simulate grassroots concern, carefully selected patient testimonials curated for congressional appearances.
These manufactured appearances work in specific contexts. They do not produce the kind of genuine affected-party knowledge that the forum is designed to aggregate. The patient whose testimony was arranged by a pharmaceutical manufacturer’s public affairs team is not producing the same knowledge as the patient who is describing their specific experience navigating the denial system without a script. The organized appearance and the genuine account look similar from the outside. They are not the same thing.
The forum’s deliberative process is specifically designed to surface the difference. People with genuine skin in the game — people whose lives are shaped by the problems they’re describing — reason differently from people performing concern. The deliberative process, where positions are tested against other affected parties with different specific experiences, where the range of what people have actually encountered is aggregated rather than curated, produces an account of how the system actually works that no manufactured testimony can replicate.
The organized interests side has the infrastructure to deliver curated knowledge to institutions. The platform is designed to aggregate genuine knowledge and make it accessible to the deliberative process that produces better policy than curated knowledge delivers.
Cross-references: Why Affected Parties Lead — americasplan.org/why-affected-parties-lead/ | On Collective Wisdom — americasplan.org/collective-wisdom/ | Prior Authorization: What Patients Experience — americasplan.org/issues/health-insurance-prior-authorization/
Forum question: What do you know from living with this problem that you have never seen captured in a policy paper, a news article, or a political argument?